Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11555019 Peptide conjugates of microtubule-targeting agents as therapeutics

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

January 17, 2023

Patent Application Number

16924445

Date Filed

July 9, 2020

Patent Citations

US Patent 10383878 Anti-HER3 antibody-drug conjugate

US Patent 10413615 Process for preparing cell-binding agent-cytotoxic agent conjugates

US Patent 10435432 Preparation of maytansinoid antibody conjugates by a one-step process

US Patent 10695396 Malignant tumor target peptide

US Patent 10844135 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said

US Patent 10729782 Antibody-drug conjugate produced by binding through linker having hydrophilic structure

US Patent 10933069 Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues

US Patent 10064855 Composite nanoparticles and uses thereof

...

Patent Primary Examiner

Daniel R Carcanague

CPC Code

The present invention relates to peptide conjugates of microtubule-targeting agents such as maytansinoid derivatives which are useful for the treatment of diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11555019 Peptide conjugates of microtubule-targeting agents as therapeutics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool